Kungani ubuhlungu besisu bungasasho ukuthi ucabangani
Uma uvame ukuzwa ubuhlungu bebele, ungase uzibuze ukuthi kuphakamisa ingozi yomdlavuza webele. Ubuhlungu besisu, noma i-mastalgia, buvame kakhulu futhi buvame ukuhlobene nezimbangela ezinobungozi. Ngabe ubuhlungu besisu bungase buhlotshaniswe nobungozi obandayo bokuthuthukisa umdlavuza webele, futhi nini lapho kuyinkinga enkulu?
Amahomoni kanye nosizi lwebele
Kukhona umehluko phakathi kobuhlungu besibindi se-cyclical and noncyclical .
Phakathi kokukhulelwa nokuya esikhathini, iningi labesifazane banezinhlungu zesifuba nesifuba sezinyosi njengoba amazinga e-hormone ashintsha. Ngesikhathi sokuya esikhathini, uma isikhathi sakho sokuya esikhathini siphela, ubuhlungu obukhulu bebele buphela. Ama-ovarie akho azokhiqiza amazinga aphansi e-estrogen ngesikhathi sokuya esikhathini, okuholela ekuvupheni kancane nangesisa emathunjini nasesisu sakho. Ubuhlungu bebele be-menopausal abuyikho futhi buvame ukulimaza esiswini esisodwa kuphela. Ubuhlungu besisu obungenayo i-noncyclical abuyona i- hormonal futhi bungabangelwa ukugula, ukulimala, inzuzo yesisindo, noma imithi ethile.
Ubunzima Bokubeletha Akusho Njalo Kusho Umdlavuza Webele
Esigabeni Sokunakekelwa Kwebele sase-University Hospital eSyracuse, eNew York, abacwaningi benza isifundo nabesifazane abangu-5463 abavakashele emtholampilo wabo. Kulaba abangu-861 kulaba besifazane abatholakala benesifo somdlavuza webele, naleso sigaba, amaphesenti angu-14 kuphela alabo besifazane abike noma yiliphi ubuhlungu bebele. Abaningi besifazane abakhononda ubuhlungu besisu babengenayo umdlavuza webele.
Ukuba nobuhlungu besisu akusizi kahle futhi kuphazamise, kodwa akuvamile ukuba uphawu lomdlavuza wesifuba, futhi ngokuvamile akwenyusa ingozi yomdlavuza.
Ezinye izifo zesisu ezincelisayo zingabangela ubuhlungu besisu, kodwa lokhu kunomthelela omncane kakhulu engozini yokuthuthukisa umdlavuza webele. Lezi zimo zesifuba zenziwe ngamangqamuzana angekho amancane, akhula futhi ahlukanise ngesilinganiso esivamile.
Izimo zesisu zohlobo lwesisu neengozi ephansi
Kubangela ubuhlungu futhi kuthinte ingozi yomdlavuza webele
Amangqamuzana angenawo amanani - isilinganiso esivamile sokukhula kwesitembu nokuhlukaniswa
- Abscess
- I-ectasia ye-Ductal
- I-necrosis yamafutha
- Izinguquko ze-Fibrocystic
- Isisu
- I-cyst sebaceous
- I-fibroadenoma elula
Izimo Zezinsana Ze-Benign Ngengozi Elinganiselwe
Kubangela ubuhlungu futhi kuphakamisa ingozi kunokujwayelekile: 150 - 200% Ukwandisa
Amaseli ahamba phambili ngaphandle kwe-atypia - okusheshayo kunokulinganisa okujwayelekile kokukhula kwamaseli ngaphandle kwamaseli angavamile
- I- fibroadenoma eyinkimbinkimbi
- I-fibroadenomas eminingi
- Ukushiswa komsindo
I-Fibroadenomas kanye nezicubu ezibomvu zingasuswa ngokuhlinzwa noma ukungabikho okungenasidingo kwe- laser, ukukhanda, amagagasi omsakazo, noma i-vacuum. I-fibroadenoma yebele kumele itholakale ene- biopsy yebele , ngakho-ke amaseli angahlolwa ukuze aphume ngaphandle kwezinye izimo.
Izimo Zokuncelisa Ubisi Nge-Risk Esiphezulu
Kubangela ubuhlungu futhi kuphakamisa ingozi kakhulu: 4 kuya ku-5 Isikhathi esivamile
I-proliferative nge-atypia - ngokushesha kunenani elivamile lokukhula kwamaseli futhi libe namaseli angavamile
- I-atypical ductal hyperplasia (ADH)
- I-otypical lobular hyperplasia (ALH)
I-Hyperplasia yisimo esibucayi lapho amangqamuzana akhula ngokushesha kunokuvamile. I-hyperplasia ye-atypical ibhekwa njengesimo esinqunyiwe. Ama-apipical amangqamuzana angavamile futhi angakwazi ukuthuthukisa umdlavuza webele ongapheli, njenge- ductal carcinoma in situ .
Xoxa ngezinzuzo zokuhlinzwa ngokususa noma iyiphi i-hyperplasia ye-atypical nodokotela wakho.
Ubuhlungu besisu, Ukwelashwa Kwama-Hormone Alternative, ne-Cancer Breast
Kulabo besifazane abasebenzisa ukwelapha okukhipha ama-hormone, ubuhlungu besifuba bungaba umthombo wokukhathazeka. EsiFundweni Sokuqala Kwezempilo Kwabesifazane - isifundo esabangela amafulegi abomvu mayelana nokusetshenziswa kwe-hormone okwenza ukuba ubuhlungu besifo somdlavuza webele bube yisisusa sokukhathazeka. Kwabesifazane abasebenzisa ukwelashwa okuhlangene-okungukuthi, i-estrogen kanye nobuhlungu besifuba se-progesterone-olusha olusha noluthando lwahlanganiswa nengozi eyengeziwe yokuthuthukisa umdlavuza webele.
Lokhu kwakungeyona indaba yokuthi abesifazane basebenzise i-estrogen esikhundleni sodwa.
Lokhu kuhlangana phakathi kobuhlungu ngemuva kokusebenzisa inhlanganisela ye-estrogen ne-progesterone ngokukhethekile ngokuphathelene nabesifazane abanesisa ngaphambi kokuqala ukwelashwa. Noma ubani ocabangela ukuxilongwa kwe-hormonal substitution esikhundleni kufanele abe nengxoxo ngokucophelela nodokotela wakhe mayelana nenengozi yokwanda komdlavuza webele kodwa ukubaluleka kobuhlungu besisu.
Okubalulekile
Kuyiqiniso ukuthi ngezinye izikhathi ubuhlungu besisu kungaba uphawu lokuqala lomdlavuza webele. Ezinye izimo zesifuba ezibuhlungu ziphakamisa ingozi, kuyilapho abanye abaningi bengaboni. Uma unezinhlungu zesifuba, ungesabi, kodwa qiniseka ukuthi ukhuluma nodokotela wakho. Umdlavuza wesibeletho ukwelashwa kakhulu ezinkathini zokuqala zesifo futhi noma yiluphi uphawu lomdlavuza webele olusha kuwe kubalulekile ukubhekana kahle.
Imithombo:
I-American Cancer Society. Yiziphi izimbangela zeengozi ze-Cancer Breast? Kubuyekezwe 01/15/16. http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-risk-zimboni
Crandall, C. et al. Ububele besisu kanye nengozi yomdlavuza webele esifundeni se-estrogen kanye ne-progestin kanye nesilingo sezempilo se-clinic esesimweni sezempilo se-estrogen-alone. Ucwaningo lwe-Cancer Research and Treatment . 2012. 132 (1): 275-85.
Khan, S., no-A.. Umdlavuza weMastalgia nesifuba: inhlangano yokuvikela ?. Ukutholakala komdlavuza nokuvimbela . 2002. 26 (3): 192-6.
McCann, B. et al. Izinhlangano eziphakathi kwama-gytokine ama-proto ne-anti-inflammatory kanye nobuhlungu besifuba kulabo besifazane ngaphambi kokuhlinzwa komdlavuza webele. I-Journal of Pain . 2012. 1 (5): 425-37.
Plu-Bureau, G., Le, M., Sitruk-Ware, R., noJ. Thalabard. I-mastalgia ye-cyclical nesifo somdlavuza webele: imiphumela yesifundo seqembu lesiFulentshi. I-Epidemiology ye-Cancer Epidemiology Biomarkers and Prevention . 2006. 5 (6): 1229-31.